Navigation Links
Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema

A new study has revealed that Acute mountain sickness (AMS), which affects about half of those ascending to heights over 3,000m, may lead to life-threatening complications such as pulmonary or cerebral edema.

The interest of the general public in AMS is thought to have increased over the past 25 years. This change is partly due to media exposure, trekking guidebooks and the wide availability of the Internet. In spite of these apparent changes, it is unknown whether there is an actual increased awareness among those who actually climb to these altitudes, and if this awareness is accompanied by a decrease in the prevalence of AMS.

The study aimed to characterize the knowledge among high-altitude trekkers regarding symptoms, prevention, and treatment of AMS, and to examine whether this knowledge is translated into practice.

92 percent had heard of AMS prior to their current trip. Overall, awareness of AMS among trekkers was good, particularly in regard to symptoms and modes of treatment. Almost 90 percent of the travellers were found to have basic knowledge of AMS and could recognize its symptoms (such as headache, plus 2 or more of the following: fatigue, dizziness, nausea, insomnia). 72 percent knew that descent was the primary mode of treatment. However, a fundamental mode of treatment, oxygen, was known to less than 10 percent of travellers.

47 percent of those surveyed suffered from AMS and nearly 25 percent of the participants did not know that AMS could be prevented. Additionally, 15 percent of those surveyed believed AMS to start above 4,000m, placing them at risk at altitudes between 3,000m and 4,000m.

Implementation is lacking for translating seemingly adequate knowledge of AMS into practical action. The findings indicate that there is room for improvement, and they offer a major challenge to travel health care providers. Pre-travel consultation regarding AMS should be given by profession als with special attention to practical advice.

This study is published in Journal of Travel Medicine.


'"/>




Related medicine news :

1. Acute Measles Supresses HIV Replication
2. Severe Acute respiratory Syndrome (SARS)
3. WHO Travel Advice to prevent spread of "Severe Acute Respiratory Syndrome (SARS)
4. Acute Pancreatitis On The Rise Due To Alcohol Consumption
5. Promised Drug Doesnt Help Acute Heart Failure
6. Gene Fusion Test to screen children’s with Acute Lymphoblastic Leukemi
7. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
8. Acute Gastroenteritis Responds To Treatment With Either Gatorade Or Pedialyte
9. Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million!
10. Acute Shortage Of Dentists in UK: Oral Care for Elders To Suffer A Setback
11. Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology: